Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 1
2019 1
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Macrophages in Cancer Development and Therapy.
Cendrowicz E, Sas Z, Bremer E, Rygiel TP. Cendrowicz E, et al. Cancers (Basel). 2021 Apr 18;13(8):1946. doi: 10.3390/cancers13081946. Cancers (Basel). 2021. PMID: 33919517 Free PMC article. Review.
Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity.
Ustyanovska Avtenyuk N, Choukrani G, Ammatuna E, Niki T, Cendrowicz E, Lourens HJ, Huls G, Wiersma VR, Bremer E. Ustyanovska Avtenyuk N, et al. Among authors: cendrowicz e. Biomedicines. 2021 Dec 29;10(1):66. doi: 10.3390/biomedicines10010066. Biomedicines. 2021. PMID: 35052746 Free PMC article.
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma.
Freile JÁ, Ustyanovska Avtenyuk N, Corrales MG, Lourens HJ, Huls G, van Meerten T, Cendrowicz E, Bremer E. Freile JÁ, et al. Among authors: cendrowicz e. Biomedicines. 2022 May 19;10(5):1175. doi: 10.3390/biomedicines10051175. Biomedicines. 2022. PMID: 35625912 Free PMC article.
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Cendrowicz E, Jacob L, Greenwald S, Tamir A, Pecker I, Tabakman R, Ghantous L, Tamir L, Kahn R, Avichzer J, Aronin A, Amsili S, Zorde-Khvalevsky E, Gozlan Y, Vlaming M, Huls G, van Meerten T, Dranitzki ME, Foley-Comer A, Pereg Y, Peled A, Chajut A, Bremer E. Cendrowicz E, et al. J Exp Clin Cancer Res. 2022 Mar 14;41(1):97. doi: 10.1186/s13046-022-02256-x. J Exp Clin Cancer Res. 2022. PMID: 35287686 Free PMC article.
Bacillus subtilis SepF binds to the C-terminus of FtsZ.
Cendrowicz E, van Kessel SP, van Bezouwen LS, Kumar N, Boekema EJ, Scheffers DJ. Cendrowicz E, et al. PLoS One. 2012;7(8):e43293. doi: 10.1371/journal.pone.0043293. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912848 Free PMC article.
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.
Bouwstra R, He Y, de Boer J, Kooistra H, Cendrowicz E, Fehrmann RSN, Ammatuna E, Zu Eulenburg C, Nijland M, Huls G, Bremer E, van Meerten T. Bouwstra R, et al. Among authors: cendrowicz e. Cancer Immunol Res. 2019 Oct;7(10):1663-1671. doi: 10.1158/2326-6066.CIR-18-0781. Epub 2019 Aug 13. Cancer Immunol Res. 2019. PMID: 31409608